Michal Douša

1.1k total citations
59 papers, 907 citations indexed

About

Michal Douša is a scholar working on Spectroscopy, Analytical Chemistry and Molecular Biology. According to data from OpenAlex, Michal Douša has authored 59 papers receiving a total of 907 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Spectroscopy, 26 papers in Analytical Chemistry and 14 papers in Molecular Biology. Recurrent topics in Michal Douša's work include Analytical Chemistry and Chromatography (41 papers), Analytical Methods in Pharmaceuticals (18 papers) and Microfluidic and Capillary Electrophoresis Applications (12 papers). Michal Douša is often cited by papers focused on Analytical Chemistry and Chromatography (41 papers), Analytical Methods in Pharmaceuticals (18 papers) and Microfluidic and Capillary Electrophoresis Applications (12 papers). Michal Douša collaborates with scholars based in Czechia, Italy and France. Michal Douša's co-authors include Lucie Nováková, Karel Lemr, Sandra Furlanetto, Serena Orlandini, Massimo Del Bubba, Benedetta Pasquini, Jan Doubský, Roberto Gotti, Juraj Ševčı́k and Joanna Znaleziona and has published in prestigious journals such as Journal of Chromatography A, Molecules and Analytica Chimica Acta.

In The Last Decade

Michal Douša

59 papers receiving 823 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michal Douša Czechia 19 546 377 269 203 127 59 907
Hana Sklenářová Czechia 22 507 0.9× 739 2.0× 386 1.4× 118 0.6× 84 0.7× 83 1.3k
Alina Plenis Poland 19 318 0.6× 318 0.8× 238 0.9× 216 1.1× 173 1.4× 85 938
Krzysztof Goryński Poland 20 566 1.0× 669 1.8× 340 1.3× 381 1.9× 60 0.5× 43 1.4k
Hsin‐Lung Wu Taiwan 21 548 1.0× 368 1.0× 321 1.2× 283 1.4× 240 1.9× 89 1.4k
Alireza S. Kord United States 16 516 0.9× 376 1.0× 194 0.7× 157 0.8× 53 0.4× 23 829
Yolanda Martı́n-Biosca Spain 19 668 1.2× 254 0.7× 422 1.6× 232 1.1× 59 0.5× 65 1.0k
Victor David Romania 19 361 0.7× 356 0.9× 163 0.6× 148 0.7× 76 0.6× 48 1.1k
Dao T.‐T. Nguyen Switzerland 10 699 1.3× 362 1.0× 391 1.5× 400 2.0× 94 0.7× 11 1.0k
Gengli Duan China 20 320 0.6× 298 0.8× 106 0.4× 354 1.7× 113 0.9× 59 1.2k
Adela Sevillano-Cabeza Spain 19 445 0.8× 439 1.2× 158 0.6× 144 0.7× 148 1.2× 49 940

Countries citing papers authored by Michal Douša

Since Specialization
Citations

This map shows the geographic impact of Michal Douša's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Douša with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Douša more than expected).

Fields of papers citing papers by Michal Douša

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michal Douša. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Douša. The network helps show where Michal Douša may publish in the future.

Co-authorship network of co-authors of Michal Douša

This figure shows the co-authorship network connecting the top 25 collaborators of Michal Douša. A scholar is included among the top collaborators of Michal Douša based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Douša. Michal Douša is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Khalikova, Maria, et al.. (2023). What is the role of current mass spectrometry in pharmaceutical analysis?. Mass Spectrometry Reviews. 43(3). 560–609. 24 indexed citations
3.
Douša, Michal, et al.. (2020). HILIC-MS determination of dimethylamine in the active pharmaceutical ingredients and in the dosage forms of metformin. Journal of Pharmaceutical and Biomedical Analysis. 191. 113573–113573. 15 indexed citations
4.
Douša, Michal, et al.. (2020). Detection and structure elucidation of the new degradation impurities in the pharmaceutical formulations of ruxolitinib hydrobromide. Journal of Pharmaceutical and Biomedical Analysis. 186. 113266–113266. 5 indexed citations
5.
Rudovský, J., et al.. (2020). Insight into the formation of N-nitrosodimethylamine in metformin products. Journal of Pharmaceutical and Biomedical Analysis. 195. 113877–113877. 24 indexed citations
6.
7.
Douša, Michal, et al.. (2018). Identification and structure elucidation of a new degradation impurity in the multi-component tablets of amlodipine besylate. Journal of Pharmaceutical and Biomedical Analysis. 162. 112–116. 6 indexed citations
8.
Douša, Michal, et al.. (2017). Esterification of Ibuprofen in Soft Gelatin Capsules Formulations—Identification, Synthesis and Liquid Chromatography Separation of the Degradation Products. Journal of Chromatographic Science. 55(8). 790–797. 2 indexed citations
9.
Douša, Michal, et al.. (2017). HPLC/UV/MS method application for the separation of obeticholic acid and its related compounds in development process and quality control. Journal of Pharmaceutical and Biomedical Analysis. 149. 214–224. 8 indexed citations
10.
Douša, Michal, et al.. (2016). A novel approach for HPLC determination of 2-cynaoacetamide using derivatization procedure with 2-hydroxyacetophenone as a new useful derivatization reagent. Journal of Pharmaceutical and Biomedical Analysis. 128. 391–397. 6 indexed citations
11.
Plachká, Kateřina, et al.. (2016). Development, validation and comparison of UHPSFC and UHPLC methods for the determination of agomelatine and its impurities. Journal of Pharmaceutical and Biomedical Analysis. 125. 376–384. 15 indexed citations
12.
Douša, Michal, S. Rádl, Jaroslav Havlı́ček, et al.. (2014). Identification, characterization, synthesis and HPLC quantification of new process-related impurities and degradation products in retigabine. Journal of Pharmaceutical and Biomedical Analysis. 94. 71–76. 24 indexed citations
13.
Douša, Michal, et al.. (2012). The Formation of Furfural Compounds in Selected Saccharide- and Polysaccharide-based Pharmaceutical Excipients. Journal of Pharmaceutical Sciences. 101(5). 1811–1820. 10 indexed citations
14.
Douša, Michal & Karel Lemr. (2011). Liquid chromatographic method for enantiopurity control of alaptide using polysaccharide stationary phases. Journal of Separation Science. 34(12). 1402–1406. 3 indexed citations
15.
Douša, Michal, et al.. (2011). Drug-excipient compatibility testing—Identification and characterization of degradation products of phenylephrine in several pharmaceutical formulations against the common cold. Journal of Pharmaceutical and Biomedical Analysis. 55(5). 949–956. 16 indexed citations
16.
Douša, Michal, et al.. (2010). Liquid chromatographic separation of pregabalin and its possible impurities with fluorescence detection after postcolumn derivatization with o-phtaldialdehyde. Journal of Pharmaceutical and Biomedical Analysis. 53(3). 717–722. 34 indexed citations
17.
Douša, Michal, et al.. (2007). HPLC Determination of Vitamin E in Feed Materials, Compounded Feeds and Foods. Chemické listy. 101(7). 3 indexed citations
18.
Douša, Michal, et al.. (2005). HPLC determination of lincomycin in premixes and feedstuffs with solid-phase extraction on HLB OASIS and LC–MS/MS confirmation. Journal of Pharmaceutical and Biomedical Analysis. 40(4). 981–986. 29 indexed citations
19.
Douša, Michal, et al.. (2004). Rapid determination of amoxicillin in premixes by HPLC. Journal of Pharmaceutical and Biomedical Analysis. 37(2). 373–377. 85 indexed citations
20.
Douša, Michal, et al.. (2002). Optimization of the HPLC Method with Postcolumn Derivatization for Determination of Amprolium in Fodders at Contents Lower than 5 mg/kg. Chemické listy. 96(9). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hana Sklenářová Breakdown of academic impact, for papers by Alina Plenis Breakdown of academic impact, for papers by Krzysztof Goryński Breakdown of academic impact, for papers by Hsin‐Lung Wu Breakdown of academic impact, for papers by Alireza S. Kord Breakdown of academic impact, for papers by Yolanda Martı́n-Biosca Breakdown of academic impact, for papers by Victor David Breakdown of academic impact, for papers by Dao T.‐T. Nguyen Breakdown of academic impact, for papers by Gengli Duan Breakdown of academic impact, for papers by Adela Sevillano-Cabeza
Rankless by CCL
2026